Table 2.
Capsaicin 8% patch (n = 282) | Pregabalin (n = 277) | |
---|---|---|
Patients with TEAEs (n, %) | 210 (74.5) | 177 (63.9) |
Patients with drug‐related TEAEs (n, %) | 173 (61.3) | 151 (54.5) |
Days free from TEAEs (%, SD) | 84.3 ± 26.5 | 64.5 ± 39.5 |
Days free from drug‐related TEAEs (%, SD) | 94.5 ± 15.8 | 70.4 ± 37.9 |
SAS: Safety analysis set; SD: Standard deviation; TEAEs: Treatment‐emergent adverse events.